For the year ending 2025-12-31, AMPH made $719,887K in revenue. $98,094K in net income. Net profit margin of 13.63%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 719,887 | 731,967 | ||
| Cost of revenues | 363,830 | 358,112 | ||
| Gross profit | 356,057 | 373,855 | ||
| Selling, distribution, and marketing | 43,885 | 37,802 | ||
| General and administrative | 85,925 | 56,720 | ||
| Research and development | 85,844 | 73,914 | ||
| Total operating expenses | 215,654 | 168,436 | ||
| Income from operations | 140,403 | 205,419 | ||
| Interest income | 8,679 | 10,612 | ||
| Interest expense | 25,481 | 30,343 | ||
| Other income (expenses), net | 23 | 4,076 | ||
| Total non-operating income (expenses), net | -16,779 | -15,655 | ||
| Income before income taxes | 123,624 | 189,764 | ||
| Income tax provision | 25,530 | 29,672 | ||
| Income before equity in losses of unconsolidated affiliate | 98,094 | 160,092 | ||
| Equity in losses of unconsolidated affiliates | - | -573 | ||
| Net income attributable to amphastar pharmaceuticals, inc | - | 159,519 | ||
| Net income | 98,094 | 159,519 | ||
| Basic EPS | 2.1 | 3.29 | ||
| Diluted EPS | 2.03 | 3.06 | ||
| Basic Average Shares | 46,743,000 | 48,429,000 | ||
| Diluted Average Shares | 48,215,000 | 52,058,000 | ||
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)